- Presentations
- 2
- Markets
- 1
Invega Hafyera is a brand of Paliperidone palmitate marketed by Janssen Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Paliperidone palmitate
- Brand owner
- Janssen Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 1092 mg/3.5 mL extended-release injectable suspension, 1560 mg/5 mL extended-release injectable suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Invega Hafyera 1092 mg/3.5 mL extended-release injectable suspensionIntramuscular | Janssen Pharmaceuticals | US FDA | Available on request |
| Invega Hafyera 1560 mg/5 mL extended-release injectable suspensionIntramuscular | Janssen Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Paliperidone palmitate.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Invega Hafyera
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.